The articles contained in Energy Transitions summarise a series of eight high-level policy symposia on Europe’s energy future organized between 2011 and 2014 by Science|Business and supported by BP.
Advocates for cross-sectoral R&D support fear a downgrade in the new Commission – but in individual areas such as energy, digital technologies, and pharmaceuticals, a stronger emphasis on growth and investment is good news for many
With Europe’s biggest-ever research programme, Horizon 2020, now underway, Science|Business gathered several leaders in European research, industry and policy to debate the ethical questions that may arise. Their reflections, gathered here, are part of a Science|Business effort to spotlight the ethical dimensions of this vital new EU initiative.
Dynamic small companies are a key to driving economic growth; that much we all know. But what helps those companies grow? For a technologybased company, one answer is obvious: The ideas on which they found the company. In short, their intellectual property.
Over the past five years, the US shale gas boom has brought about dramatic changes in the North American energy landscape, prompting economic and environmental debate in Europe and other parts of the world. In the US, energy prices have fallen dramatically, helping drive economic recovery from the global recession. But the spread of hydraulic fracturing or “fracking” – the technology used to drill for shale gas – has raised the ire of environmentalists.
Over the past five years the Science|Business Academic Enterprise Awards have thrown a spotlight on 70 of Europe’s hottest technology spin-outs. The ACES winners are individuals who created companies based on cutting-edge research.
High performance computing now underpins top class science across all disciplines and is an essential tool for industry, shortening development cycles whilst at the same time improving the reliability and quality of products.
Third generation cognitive computing is making sense of data mountains and starting to deliver remarkable improvements in healthcare. Now, sensitively calibrated data protection rules are needed – to reassure patients and protect privacy, whilst allowing progress to continue.
